These are this morning’s top day trader alert and actively traded stocks. We have links through to each with more detailed price and volume data and analysis over at VSInvestor.com:
CIT Group, Inc. (NYSE: CIT) is down over 20% after it delayed its 10-Q filing amid restructuring. Worse talk is out there…
Anadys Pharma (NASDAQ: ANDS) is up 30% or more on early clinical trial in Hepatitis C patient data.
Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) is hitting 52-week highs after showing positive Phase III study results for Zenvia.
Bunge Limited (NYSE: BG) is down 4% on a surprise secondary offering.
Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI) is up over 30% as a license holder reported a CE Mark approval.
RINO International Corporation (NASDAQ: RINO) was very active last night after earnings and is down 17% this morning.
JON C. OGG
AUGUST 11, 2009
Travel Cards Are Getting Too Good To Ignore (sponsored)
Credit card companies are pulling out all the stops, with the issuers are offering insane travel rewards and perks.
We’re talking huge sign-up bonuses, points on every purchase, and benefits like lounge access, travel credits, and free hotel nights. For travelers, these rewards can add up to thousands of dollars in flights, upgrades, and luxury experiences every year.
It’s like getting paid to travel — and it’s available to qualified borrowers who know where to look.
We’ve rounded up some of the best travel credit cards on the market. Click here to see the list. Don’t miss these offers — they won’t be this good forever.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.